Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold.
The global ultra-low temperature freezers market is expected to grow from $805.47 million in 2021 to $851.35 million in 2022 at a compound annual growth rate (CAGR) of 5.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $1,064.02 million in 2026 at a CAGR of 5.7%.
The ultra-low temperature freezers market consists of sales of ultra-low temperature freezers by entities (organizations, sole traders, and partnerships) that manufacture ultra-low temperature freezers.Ultra-low temperature freezers are a form of a freezer that can keep temperatures between-80 and-86 degrees Celsius.
An ultra-low temperature freezer is also known as a minus 80 freezer or a negative 80 freezer. Only goods and services traded between entities or sold to end consumers are included.
The main types of ultra-low temperature freezers are chest freezers and upright freezers.A chest freezer is a cabinet freezer with a door that lifts up to open.
The freezers are used for blood and blood products, organs, pharmaceuticals, forensic, genomic research applications by bio-banks, pharmaceutical and biotechnology companies, academic and research laboratories and other end-users.
North America was the largest region in the ultra-low temperature freezers market in 2021. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The COVID-19 outbreak is propelling the growth of the ultra-low temperature freezer market in the coming years.Scientists are trying hard to create a vaccine and depending on ultra-low temperature freezers and incubators to retain novel coronavirus samples so that they can be recovered whenever appropriate and examined to gain insight into this emerging respiratory illness.
For example, the BINDER CO2 freezer is helping researchers and scientists to retain coronavirus samples.These freezers are important because they provide protection and anti-contamination features.
Therefore, the COVID-19 outbreak contributed to the growth of the ultra-low temperature freezer market.
The high costs associated with ultra-low temperature (ULT) freezers are expected to hinder the growth of the ultra-low temperature freezers market in the coming years.Ultra-low temperature (ULT) sample storage freezers are a central component of a majority of labs, biobanks, and pharmacies around the world.
These units allow the medium to the long-term preservation of numerous biological samples, such as cell extracts, proteins, RNA, or DNA.A fixed temperature of -20 °C or -40 °C can be sustained by a regular upright mechanical freezer, but the majority would operate at -80 °C.
To maintain a lower temperature, a stable power source is required that leads to additional energy and operating costs.An upright, mechanical ULT freezer can fluctuate in average operating expenses from $750 to $1000 per year.
Therefore, the high costs associated with ultra-low temperature (ULT) freezers incurs huge operational costs that are difficult for small and medium enterprises and hampers the growth of the ultra-low temperature freezers market.
Major companies operating in the ultra-low temperature freezers sector are focusing on developing technology advanced solutions for ultra-low temperature freezers.For example, in May 2020, Thermo Fisher Scientific, a US-based biotechnology company, launched a new service that gathers and tracks key performance data from the attached TSX Series ULT freezers to provide an optimum sample and product safety.
The Thermo Scientific smart connected systems function tracks 37 types of alarms and 26 operational parameters for the user to provide a detailed analysis of the linked TSX Series ULT freezers.
In June 2019, PHC Holdings Corporation, a Japan-based healthcare company acquired the anatomical pathology business of Thermo Fisher Scientific for $1.14 billion. The anatomical pathology business acquired by PHC Holdings Corporation will operate as a new stand-alone company under the name Epredia. The new company will continue to provide comprehensive solutions in the anatomical pathology field, including microscope slides, consumables, instruments. Thermo Fisher Scientific is a US-based biotechnology company engaged in manufacturing and selling ultra-low temperature freezers market.
The countries covered in the ultra-low temperature freezers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• May 2022
Major players in the critical illness market are China Life Insurance, Allianz, Ping An Insurance, Aviva, Legal & General, China Pacific Insurance, Prudential plc, New China Life Insurance, Aegon, and AXA. The global critical illness insurance market is expected to grow from $185.53 billion in 2021 to $215.49 billion in 2022 at a compound...
200 pages •
By The Business Research Company
• May 2022
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated. The global anatomic pathology equipment and consumables...
The global anti-rheumatics market reached a value of US$ 61.1 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 72.1 Billion by 2027, exhibiting at a CAGR of 2.74% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
120 pages •
By Infiniti Research Limited
• Jun 2022
Global Nasal Implants Market 2022-2026 The analyst has been monitoring the nasal implants market and it is poised to grow by $ 312.05 million during 2022-2026, accelerating at a CAGR of 5.26% during the forecast period. Our report on the nasal implants market provides a holistic analysis, market size and forecast, trends,...
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Aryl Hydrocarbon Receptor - Drugs In Development,...
The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity.This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently...
The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 18.104.22.168) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 22.214.171.124) - Janus kinase 2 is a non-receptor tyrosine...
Stem Cell Transplantation
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.